28.0
SAB Biotherapeutics, Inc.
Metrics score locked — part of Premium
FY22
FY22
FY23
FY24
FY25
FY22 – FY25
Assets
(positive)
Change from FY22 to FY25
millions USD
FY22:
FY22:
22.1
FY23:
58.9
FY24:
23.8
FY25:
101
(positive)
Change from FY22 to FY25
millions USD
FY22:
31.4
FY22:
28.8
FY23:
25.0
FY24:
20.4
FY25:
71.8
Total assets
Change from FY22 to FY25
millions USD
FY22:
59.4
FY22:
50.9
FY23:
83.9
FY24:
44.2
FY25:
173
Liabilities & Equity
(negative)
Change from FY22 to FY25
millions USD
FY22:
16.4
FY22:
15.0
FY23:
10.8
FY24:
7.98
FY25:
10.7
(negative)
Change from FY22 to FY25
millions USD
FY22:
5.90
FY22:
4.85
FY23:
15.8
FY24:
10.2
FY25:
10.6
(positive)
Change from FY22 to FY25
millions USD
FY22:
37.1
FY22:
31.1
FY23:
57.3
FY24:
26.0
FY25:
151
Total liabilities & equity
Change from FY22 to FY25
millions USD
FY22:
59.4
FY22:
50.9
FY23:
83.9
FY24:
44.2
FY25:
173
All amounts in millions USD